XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Share Based Compensation (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share Based Compensation Expense and Related Income Tax Benefit

The following table summarizes share-based compensation expense and the related income tax benefit recognized for the Company’s share-based compensation awards. Share-based compensation expenses are recorded within Selling, general and administrative in the Company’s Condensed Consolidated Statement of Operations.

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

($ in millions)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Share-based compensation expense

 

$

6.5

 

 

$

5.9

 

 

$

10.6

 

 

$

9.0

 

Income tax benefit

 

 

0.2

 

 

 

1.0

 

 

 

1.3

 

 

 

2.2

 

Schedule of Outstanding Performance Stock Units Activity, Restricted Stock Awards, Restricted Stock Units and Performance-based Stock Options

Activities for RSAs for the six months ended June 30, 2023 are as follows:

 

 

Class A Common Stock

 

 

Weighted Average Grant Date Fair Value

 

Unvested at December 31, 2022

 

 

2,111,635

 

 

$

16.23

 

Granted

 

 

2,533,649

 

 

 

6.16

 

Forfeited (1)(2)

 

 

251,387

 

 

 

15.83

 

Vested

 

 

529,614

 

 

 

15.75

 

Unvested at June 30, 2023

 

 

3,864,283

 

 

$

9.72

 

 

 

 

 

 

 

 

Activities for RSUs for the six months ended June 30, 2023 are as follows:

 

 

 

Class A Common Stock

 

 

Weighted Average Grant Date Fair Value

 

Unvested at December 31, 2022

 

 

108,909

 

 

$

13.22

 

Granted

 

 

171,384

 

 

 

7.41

 

Forfeited

 

 

 

 

 

 

Vested

 

 

108,909

 

 

 

13.22

 

Unvested at June 30, 2023

 

 

171,384

 

 

$

7.41

 

 

 

 

 

 

 

 

Activities for PSUs for the six months ended June 30, 2023 are as follows:

 

 

 

Class A Common Stock (3)

 

 

Weighted Average Grant Date Fair Value

 

Unvested at December 31, 2022

 

 

634,023

 

 

$

19.19

 

Granted

 

 

1,102,497

 

 

 

8.87

 

Forfeited

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Unvested at June 30, 2023

 

 

1,736,520

 

 

$

12.64

 

 

 

 

 

 

 

 

(1)
The forfeited shares include the Company’s failure to meet certain performance measures and employee terminations during the six months ended June 30, 2023; further, these forfeited shares are added back to the amount of shares available for grant under the Incentive Plan.
(2)
Upon vesting, award-holders elected to sell shares to the Company in order to satisfy the associated tax obligations. The awards are not deemed outstanding; further, these forfeited shares are added back to the amount of shares available for grant under the Incentive Plan.
(3)
Represent shares to be paid out at target level.

Activities for PSOs for the six months ended June 30, 2023 are as follows:

 

 

 

Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (in years)

 

 

Aggregate Intrinsic Value

 

Outstanding at December 31, 2022

 

 

 

 

$

 

 

 

 

 

$

 

Granted

 

 

1,148,822

 

 

 

6.13

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2023

 

 

1,148,822

 

 

$

6.13

 

 

 

7.0

 

 

$

1,952,997

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options vested and exercisable at June 30, 2023

 

 

 

 

$

 

 

 

 

 

$

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Fair value was estimated on the date of grant using Monte Carlo simulation with the following weighted average assumptions:

 

 

 

Three Months Ended June 30, 2023

 

 

Six Months Ended June 30, 2023

 

Risk-free interest rate

 

 

3.42

%

 

 

3.42

%

Expected volatility

 

 

52.82

%

 

 

52.82

%

Dividend yield

 

 

0

%

 

 

0

%

Expected term (in years)

 

 

4.5

 

 

 

4.5